These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 27640617)

  • 1. [Risk of thromboembolism in atrial fibrillation].
    Csanádi Z
    Orv Hetil; 2016 Sep; 157(38):1511-5. PubMed ID: 27640617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Selçuk H; Selçuk MT; Maden O
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving strategies to prevent stroke and thromboembolism in nonvalvular atrial fibrillation.
    Hussein A; Saliba W; Wazni OM
    Cleve Clin J Med; 2015 Dec; 82(12 Suppl 2):S11-6. PubMed ID: 26694887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of atrial fibrillation burden in assessing thromboembolic risk.
    Zimetbaum P; Waks JW; Ellis ER; Glotzer TV; Passman RS
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1223-9. PubMed ID: 25516580
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of thromboembolic complication in atrial fibrillation by using anticoagulants.
    Wagh K; Vikhe VB; Kumar RS; Auti N; Jose M
    J Assoc Physicians India; 2013 Dec; 61(12):894-5. PubMed ID: 24968545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anticoagulant treatment in the prophylaxis of thromboembolic complications in atrial fibrillation].
    Skrakova M; Sujanova Z
    Bratisl Lek Listy; 2001; 102(5):268-70. PubMed ID: 11725382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel oral anticoagulants for the prevention of thromboembolism in patients with atrial fibrillation.
    Lang NN; Connelly DT
    J R Coll Physicians Edinb; 2013; 43(2):151-8. PubMed ID: 23734359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke prevention in atrial fibrillation.
    Mohammed I; Mohmand-Borkowski A; Burke JF; Kowey PR
    J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):73-85. PubMed ID: 22193836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The need for new oral anticoagulants in clinical practice.
    Hylek EM
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):605-9. PubMed ID: 19571764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anticoagulation in atrial fibrillation. Strategies in special situations].
    Volkmann H; Walter M; Walter C; Vetter S
    Clin Res Cardiol Suppl; 2011 May; 6():58-65. PubMed ID: 22528179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atrial fibrillation: therapy gets more and more individualized].
    Marx N
    Dtsch Med Wochenschr; 2016 Oct; 141(22):1610. PubMed ID: 27824415
    [No Abstract]   [Full Text] [Related]  

  • 12. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China.
    Hu D; Sun Y
    J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352
    [No Abstract]   [Full Text] [Related]  

  • 13. Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.
    Zhu WG; Xiong QM; Hong K
    Tex Heart Inst J; 2015 Feb; 42(1):6-15. PubMed ID: 25873792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 15. The Health Impact Fund: how might it work for novel anticoagulants in atrial fibrillation?
    Banerjee A; Pogge T
    Glob Heart; 2014 Jun; 9(2):255-261.e2. PubMed ID: 25667097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis.
    Lip GY
    Thromb Haemost; 2008 Jul; 100(1):11-3. PubMed ID: 18612530
    [No Abstract]   [Full Text] [Related]  

  • 17. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 18. [New treatments for stroke and thromboembolism prevention in atrial fibrillation].
    Shiyovich A; Khalameizer V; Katz A
    Harefuah; 2014 Jan; 153(1):32-8, 64. PubMed ID: 24605405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy of atrial fibrillation.
    Kasliwal RR; Mukesh S; Manohar G; Aggarwal N; Bhatia A
    Asian Cardiovasc Thorac Ann; 2003 Dec; 11(4):364-74. PubMed ID: 14681106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug therapy in atrial fibrillation].
    Schuchert A
    Herzschrittmacherther Elektrophysiol; 2014 Mar; 25(1):1-2. PubMed ID: 24525719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.